Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:CFX

Colfax (CFX) Stock Price, News & Analysis

Colfax logo

About Colfax Stock (NYSE:CFX)

Key Stats

Today's Range
N/A
50-Day Range
$39.06
$127.50
52-Week Range
N/A
Volume
101,542 shs
Average Volume
1.39 million shs
Market Capitalization
$6.30 billion
P/E Ratio
84.91
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Colfax Corp. operates as a diversified technology company. The firm provides orthopedic care and fabrication technology products and services to customers. It operates through the following segments: Medical Technology and Fabrication Technology. The Medical Technology segment develops, manufactures and distributes medical devices used for rehabilitation, pain management and physical therapy. The Fabrication Technology develops, manufactures and supplies consumable products and equipment. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Colfax Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
37th Percentile Overall Score

CFX MarketRank™: 

Colfax scored higher than 37% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Colfax.

  • Earnings Growth

    Earnings for Colfax are expected to grow by 12.13% in the coming year, from $2.39 to $2.68 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Colfax is 84.91, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.55.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Colfax is 84.91, which means that it is trading at a less expensive P/E ratio than the Industrials sector average P/E ratio of about 524.50.

  • Price to Earnings Growth Ratio

    Colfax has a PEG Ratio of 0.77. PEG Ratios below 1 indicate that a company could be undervalued.

  • Short Interest

    There is no current short interest data available for CFX.
  • Dividend Yield

    Colfax does not currently pay a dividend.

  • Dividend Growth

    Colfax does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CFX.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Colfax this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for CFX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Colfax insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.20% of the stock of Colfax is held by insiders.

  • Percentage Held by Institutions

    91.99% of the stock of Colfax is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Colfax's insider trading history.
Receive CFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Colfax and its competitors with MarketBeat's FREE daily newsletter.

CFX Stock News Headlines

I want to send you my Cash Calendar
This Calendar reveals the EXACT dates that — if everything goes right — anyone can target cash payouts of $125, $415, and even $1,665. (With just a $1,000 starting stake!) Granted, there were smaller wins and those that did not work out and we cannot promise future returns or against losses, but these payouts don’t require any special knowledge or skills. Anyone can set them up with just three clicks in their brokerage account. And the money can be deposited in their account the very next morning after opening the trade. Again, I want to send this Cash Calendar to you completely FREE. All you have to do is join me for my free Cash Calendar training right here. You don’t want to miss this. There is a very special bonus surprise for everyone who attends.
See More Headlines

CFX Stock Analysis - Frequently Asked Questions

Colfax Co. (NYSE:CFX) issued its quarterly earnings results on Thursday, November, 4th. The industrial products company reported $1.62 EPS for the quarter, meeting the consensus estimate of $1.62. The firm's revenue was up 19.8% compared to the same quarter last year.

Shares of Colfax reverse split on the morning of Tuesday, April 5th 2022. The 1-3 reverse split was announced on Tuesday, April 5th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, April 5th 2022. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

Colfax subsidiaries include these companies: DJO Global, Agridzaar Limited, Airgare Limited, Arc Machines GmbH, AS ESAB, Canadian Cylinder Company Ltd., CAST Limited, and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that Colfax investors own include Endologix (ELGX), Chipotle Mexican Grill (CMG), APA (APA), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Accenture (ACN) and Micron Technology (MU).

Company Calendar

Last Earnings
11/04/2021
Today
12/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Pumps & Pumping Equipment
Sub-Industry
Industrial Machinery
CUSIP
19401410
Employees
16,200
Year Founded
2022

Profitability

Net Income
$71.66 million
Pretax Margin
4.29%

Debt

Sales & Book Value

Annual Sales
$3.85 billion
Book Value
$30.12 per share

Miscellaneous

Free Float
148,101,000
Market Cap
$6.30 billion
Optionable
Optionable
Beta
2.12

Social Links

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

This page (NYSE:CFX) was last updated on 12/19/2024 by MarketBeat.com Staff
From Our Partners